Covid-19 was created in a lab back in 2013

The origin of the virus that causes COVID-19 has been the subject
of lively debate, with the general consensus now being that it was
created in a lab rather than by nature. And when it comes to who
could be responsible for this deadly virus, Moderna is looking
increasingly guilty (https://bit.ly/36chful).
The strongest evidence can be found in a database kept by the
National Institutes of Health (NIH) and the National Center for
Biotechnology Information (NCBI). Known as BLAST, the database
catalogs all known gene sequences found in nature, along with all
synthetic gene sequences that have been patented.
Researchers decided to check BLAST for the RNA sequence of the
furin cleavage sequence found (https://bit.ly/3qqBM4Y) in the
SARS-CoV-2 spike protein to see if it could be found anywhere
else in nature. It is the only continuous nucleotide sequence in
COVID-19 that has more than three nucleotides that differ from
their respective letters in the virus’s closest natural relative, the
Bat Coronavirus RaTG13. This cleavage site is also the key to
COVID-19’s pathogenicity, making it the most likely place for
a manmade gain of function to be found in the virus. The structure
has been one of the focuses of the debate about the origins of the
virus as some scientists have long insisted that it could not have
been acquired naturally.
The researchers found five U.S. patents that contained the same
nucleotide sequence, and the earliest one had been applied for by
Moderna back in December 2013. Furthermore, it does not exist
in nature at all. The other subsequent patents were also filed by
Moderna in the years that followed.
This demonstrates that the vaccine maker actually developed the
19-nucleotide gene sequence that contains the furin cleavage site
responsible for making the virus so infectious in humans. If this
genetic tampering had not occurred, the original coronaviruses that
COVID-19 was engineered from would have only infected animals.
Researchers have said that the likelihood of a match they found to
a patent filed by Moderna on February 4, 2016, developing naturally
on its own is 1 in 3 trillion (https://bit.ly/3wpeAbj). It would
appear, therefore, that the company was already in a position
to capitalize on this virus long before the pandemic got underway.
Adding fuel to the fire is the fact that Moderna started making its
COVID-19 vaccine weeks before the first official outbreak was
reported. Their vaccine was already in development as early as
December 2019, which was at least two weeks before the confirmation
of the outbreak came from China.
Of course, we also know that the Wuhan Institute of Virology had
been carrying out gain-of-function research in bat coronavirus
samples as far back as 2015 with funding from Dr. Anthony Fauci.
The Fauci-led National Institute of Allergy and Infectious Diseases
(NIAID) started a partnership with Moderna to develop an mRNA
vaccine against the coronaviruses studied at the lab right around
that same time.
It is interesting to note, of course, that nature has never created
a virus with that sequence, yet six years after Moderna referred to
it in their patents, it has been found in a virus for which the
company has created a vaccine. Now, they have raked in billions
of dollars from their jab, which is the vaccine maker’s only
marketed product and one of just three vaccines to have been
approved for use in the U.S.
For 2021 alone, Moderna earned $12.2 billion
(https://abcn.ws/3txTVQx) in a strong reversal of fortune from
2020, when they recorded a net loss of $747 million. Analysts
have forecasted Moderna’s 2022 vaccine sales to reach $20.74
billion as boosters continue to be pushed on the masses.